Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Aytu BioPharma Inc. (AYTU) had Current Ratio of 1.26 for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$66.38M |
|
$-13.56M |
|
$20.55M |
|
$45.83M |
|
$74.21M |
|
$-7.83M |
|
$-5.92M |
|
$-13.74M |
|
$-13.74M |
|
$-14.18M |
|
$-14.18M |
|
$-13.56M |
|
$-14.18M |
|
$-7.83M |
|
$-2.34M |
|
6.28M |
|
6.28M |
|
$-2.16 |
|
$-2.16 |
|
| Balance Sheet Financials | |
$79.18M |
|
$0.53M |
|
$45.00M |
|
$124.18M |
|
$63.06M |
|
$10.89M |
|
$42.15M |
|
$105.21M |
|
$18.97M |
|
$-23.23M |
|
$18.97M |
|
8.98M |
|
| Cash Flow Statement Financials | |
$-1.94M |
|
$-2.56M |
|
$15.44M |
|
$20.01M |
|
$30.95M |
|
$10.95M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.26 |
-- |
|
-- |
|
0.36 |
|
1.15 |
|
69.04% |
|
-11.79% |
|
-11.79% |
|
-3.53% |
|
-20.71% |
|
-20.43% |
|
$-1.50M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
1.80 |
|
2.13 |
|
171.31 |
|
-74.78% |
|
61.04% |
|
-11.42% |
|
-47.49% |
|
$2.11 |
|
$-0.24 |
|
$-0.31 |
|